Strong Credit Quality and Portfolio Performance
100% of investments at cost were performing with zero investments on nonaccrual; watch list represented only 2.2% of the portfolio (unchanged from Q1 2021). Weighted average investment risk rating was under 2 on a 1-4 scale; ~98% of portfolio rated two or higher.
High Senior-Secured and First-Lien Composition
At quarter end, 94.5% of the comprehensive investment portfolio was first lien senior secured loans and ~98% of the portfolio consisted of senior secured loans, providing collateral-based downside protection versus typical cash-flow loans.
Solid Liquidity and Capital Structure
Over $900 million of capital available to deploy including facility capacity; debt outstanding ~ $1.1 billion with net debt-to-equity ratio of 1.14x (within target range 0.9x–1.25x); revolving commitments increased by $25 million to $720 million post-quarter.
Maintained NAV and Investment Grade Ratings
Net asset value per share was $18.16 as of 03/31/2026, down only 0.5% sequentially and flat year-over-year; company remains investment grade rated by Fitch, Moody’s, and DBRS.
Disciplined Portfolio Mix and Specialty Finance Growth Initiatives
Comprehensive portfolio $3.2 billion; originated $242 million of new investments in Q1 with primary origination in commercial finance strategies (ABL, equipment finance). Adviser expanding ABL sourcing partnerships and added hires in Life Sciences origination.
Action to Improve Shareholder Alignment and Future Earnings
Board declared quarterly distribution of $0.31 per share and reduced the performance-based incentive fee from 20% to 17.5% (a 12.5% relative reduction in the fee rate), aligning adviser economics with shareholders.
Attractive Asset-Level Yields in Core Strategies
Weighted average asset-level yield was 11.1% (down from 11.6% prior quarter). Segment yields: ABL 12.3% (down from 12.6%), equipment finance 10.2% (down from 10.9%), cash-flow lending ~10.0% (up from 9.8%). SSLP produced an annualized yield ~12.25% (up from 9.25%).